Navigation Links
UroToday Launches New Prostate Cancer Focused Content Including Immunotherapy for Metastatic Castration-resistant Patients
Date:12/19/2012

Berkeley, CA (PRWEB) December 19, 2012

Now in its tenth year as an online urology-medical oncology publisher, Digital Science Press, Inc. (DSP) -- UroToday.com is expanding key prostate cancer content with two new sections: immunotherapy treatment for men with metastatic castration-resistant prostate cancer; and advances in metastatic castrate-resistant prostate cancer (mCRPC) treatments for urology and oncology nurses.

“Prostate cancer is the most highly read content on the UroToday website,” says Gina Carithers, publisher, DSP. “For our worldwide readership, the disease has many aspects from screening to diagnosis to treatment -- some developing and others controversial. For example, we will continue to follow the PSA controversy and report how the evidence continues to evolve regarding the impact of PSA screening on overall survival.” UroToday is also doing more multi-media lectures on the development of new therapies and treatments that enable the urologists and medical oncologists to more effectively treat the metastatic castration-resistant prostate cancer patient.

The web platform for UroToday been upgraded to handle the increase in readership, provides easier navigation, a powerful search using Google and personalized access to the recently posted content by disease topic through daily or weekly UroAlerts. “We made an editorial decision earlier this year to focus on the “art of urology.” At conception, UroToday has reported evidence-based medicine (the science of urology); however, we are seeing a fundamental shift within many urology practices to also emphasize quality of life therapies and resources, more towards what we call the art of urology.”

Case in point, the UroToday mini-lecture series on treatments for advanced prostate cancer has now posted two lectures by medical oncologist Chuck Ryan, MD, UCSF, and one multi-media case-study by Bryan Mehlhaff, MD, Oregon Urology Institute. “The mini-lecture series format for medical professional education has been very well received,” said Carithers. “Our web format is well-suited for the hectic physician schedule and provides virtual access to any registered UroToday reader.”

UroToday has more than 10 years of scientific archived reports, and abstracts representing 33-urology disease categories. Current hot topics include all related prostate diseases and GU cancers, endourological procedures, treatments of stone disease, voiding conditions, sexual dysfunctions and Peyronie’s disease. UroToday supports the CAUTI Challenge providing online access to information about the prevention of CAUTI. In 2013, UroToday will be unveiling a urologic catheter resource center.

UroToday.com known as a urology and medical oncology online resource, released an online and print version of its 2012: Best of Prostate and Best of mCRPC interviews. The "Best of mCRPC" features an interview with Deepak Kapoor, MD, President of LUGPA. Presentation highlights and commentary include Charles J. Ryan, MD; Terry FritzPatrick, OUI administrator; Bryan A. Mehlhaff, MD; and Judd W. Moul, MD. The "Best of Prostate" focuses on the PSA controversy with comments from international experts: Peter T. Scardino, MD; William J. Catalona, MD; Alan J. Wein, MD; Fritz H. Schoder, MD; and Monique Roobol, PhD. A downloadable version of The UroToday 2012: Best of Prostate Cancer Surveillance and Screening and the Best of mCRPC is now available at UroToday.

About UroToday: Gina Carithers, CEO and Publisher, Digital Science Press, Inc. founded the online urologic website in 2003 in Berkeley, CA. This worldwide, medical resource focuses on prostate, bladder and renal cancers and urologic health issues impacting men and women’s health, including catheter selection and infection prevention. UroToday.com represents the largest online urology-oncology community. With more than 50 new content items posted daily, readers can access at no charge, by registering at http://www.urotoday.com. UroToday International Journal (http://www.UIJ.com) is a peer-review online journal, and features articles on all urological topics, including original research, review articles and case studies.

Read the full story at http://www.prweb.com/releases/2012UroToday/12Best_Of_Prostate_Cancer/prweb10249752.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. Graphic Design Company, Project6 Design, Launches New Brand And Responsive Website For Innovative Biotech Company PaxVax
2. Bayer CropScience Launches Third Annual Young Farmer Sustainability Award Program
3. Regenetek Research Inc. Launches New Intelligent Software for Therapeutic Stem Cell Trials
4. Amarantus Bioscience Launches Online Corporate Communication Channels
5. GeneTex Launches New Antibody Against Phosphorylated Histone H3 for Epigenetics Research
6. Adaptive Biotechnologies launches clonoSEQ, a more sensitive, accurate assay to detect minimal residual disease (MRD) in blood-based cancers.
7. ArteryHealth.org Launches as a Collective Database of Artery Health Research
8. Piedmont Chemical Launches 100 Percent Renewable Polyester Polyols Leveraging Renewable Chemicals from DuPont Tate & Lyle Bio Products and Myriant Corporation
9. Assay Depot Launches Make Your Mark Science Competition For High School Students
10. A New Dawn in Cosmetics Coverage: Cosmetics Design Launches Asia-Pacific News Website
11. Columbias Nursing School Launches "Keep It Clean for Kids" (KICK)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... HOUSTON , June 23, 2016 ... agreement with the Cy-Fair Sports Association to serve ... of the agreement, Houston Methodist Willowbrook will provide ... education and connectivity with association coaches, volunteers, athletes ... partner with the Cy-Fair Sports Association and to ...
(Date:6/23/2016)... 23, 2016   EpiBiome , a precision microbiome ... in debt financing from Silicon Valley Bank (SVB). The ... to advance its drug development efforts, as well as ... "SVB has been an incredible strategic partner to ... traditional bank would provide," said Dr. Aeron Tynes ...
(Date:6/23/2016)... June 23, 2016 Apellis Pharmaceuticals, Inc. ... clinical trials of its complement C3 inhibitor, APL-2. ... multiple ascending dose studies designed to assess the ... subcutaneous injection in healthy adult volunteers. ... as a single dose (ranging from 45 to ...
(Date:6/23/2016)... ... June 23, 2016 , ... ClinCapture, the only free validated ... will showcase its product’s latest features from June 26 to June 30, 2016 ... on Disrupting Clinical Trials in The Cloud during the conference. DIA (Drug ...
Breaking Biology Technology:
(Date:6/22/2016)... -- The American College of Medical Genetics and Genomics was once ... one of the fastest-growing trade shows during the Fastest 50 ... Las Vegas . Winners ... each of the following categories: net square feet of paid ... The 2015 ACMG Annual Meeting was ranked 23 out of ...
(Date:6/20/2016)... DALLAS , June 20, 2016 ... criminal justice technology solutions for public safety, investigation, ... by the prisons involved, it has secured the ... Corrections (DOC) facilities for Managed Access Systems (MAS) ... (4) additional facilities to be installed by October, ...
(Date:6/9/2016)... Paris Police Prefecture ... solution to ensure the safety of people and operations in ... major tournament Teleste, an international technology group specialised ... today that its video security solution will be utilised by ... public safety across the country. The system roll-out is scheduled ...
Breaking Biology News(10 mins):